profit from every €100 of sales.
€0€100
BB Biotech
€59.50-0.50% today
+78.1% since Dec 19, 25
1-year low €33.401-year high €59.80
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2024 to 2025.
0%20% a year
You pay €5.24 for every €1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What BB Biotech sold, what it kept, and what it did with the cash.
Sales went from -CHF 351 million in 2022 to CHF 587 million in 2025, with CHF 578 million of profit last year.
SalesProfit
BB Biotech handed back 33% of the cash it generated last year.
CHF 98M
Free cash flow 2025CHF 309M
Bought back its own sharesCHF 5M
Paid as dividendsCHF 98M
BB Biotech vs. similar companies
BB Biotech grows the fastest of these 5 and is the cheapest for its profits.
| Company | Profit from €100 of sales | Sales growth a year | Price per €1 of profit |
|---|---|---|---|
| BB Biotech | 5.2× · Cheap | ||
 Vertex Pharmaceuticals | 34.8× · Expensive | ||
 Regeneron Pharmaceuticals | 21.8× · Fair price | ||
 Moderna | No profit yet | ||
 CSL | 22.3× · Fair price |
AI analysis
An AI analyst reads BB Biotech's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of CHF | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -351 | -200 | 82 | 587 | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – | |
| -358 | -207 | 76 | 578 | |
| -6.50 | -3.77 | 1.38 | 10.54 | |
| – | – | – | – | |
| – | – | – | – | |
| 101.9% | 103.5% | 92.2% | 98.5% |
Balance sheet
| In millions of CHF | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 3,053 | 2,637 | 2,407 | 2,786 |
| Cash | 2 | 1 | 0 | 98 |
| Total debt | 363 | 305 | 118 | – |
| Total liabilities | 367 | 314 | 121 | 7 |
| 2,686 | 2,323 | 2,286 | 2,779 | |
| 55 | 55 | 55 | 55 | |
| – | – | – | – | |
| -13.3% | -8.9% | 3.3% | 20.8% |
Cash flow
| In millions of CHF | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | – | – | |
| – | – | – | – | |
| 231 | 218 | 305 | 309 | |
| Dividends paid | 212 | 156 | 110 | 98 |
| 27 | 0 | 3 | 5 | |
| – | – | – | – |
Valuation
- 5.2×
- –
- 0.01
- 0.9×
- 5.2×
- 9.8×
- –
- 10.2%
- 19.1%
- 3.3%
Profitability
- –
- –
- 98.5%
- –
- –
- –
- –
- –
- –
- –
Growth
- +613.1%
- +663.8%
- –
- –
- −0.1%
Financial health
- –
- –
- –
- –
- –
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 3%of 576
Top 8%of 985
3.3%of the share price, paid each year
On $1,000 invested$33a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
17.0% of its profit
Room to growStretchedMore than it earns: 31.9%
News
The Top 5 Biotech Stocks I'd Buy Right Now Without Any HesitationYahoo Finance · Nov 8, 2026Cathie Wood-Led Ark Loads Up On GOOG, AMD, NVDA And Biotech Stocks — But Sells CRWV, AVGO, LLYYahoo Finance · Nov 7, 2026Stock Market Today: Dow Dips On Election Day; These Biotech, Insurance Stocks Clear Entries (Live Coverage)Yahoo Finance · Nov 3, 20261 Dividend-Paying Biotech Stock to Buy Hand Over Fist in NovemberYahoo Finance · Nov 1, 20265 Best Biotech Stocks Under $10 to BuyYahoo Finance · Oct 31, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
Not enough data
Questions about BB Biotech
Is BB Biotech a good stock to buy?
A strong, very profitable business, and the price looks low. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the BB Biotech AI analysis
What does BB Biotech do?
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. It is in Biotechnology, based in Küsnacht, Switzerland, with 10 employees.
Does BB Biotech pay a dividend?
Yes. At today's price the dividend is 3.3% a year, about 17% of its yearly profit. In 2025 it paid out €98.5 million in dividends.
Who are BB Biotech's competitors?
The largest listed companies in the same industry are Vertex Pharmaceuticals, Regeneron Pharmaceuticals, Moderna and CSL. The peers table on this page compares their profit, growth and price with BB Biotech's.
Prices: daily closes to Nov 12, 2026. Fundamentals: company reports via invest-like data.